Harnessing Vδ1<sup>+</sup> T cells for next-generation immunotherapy: from mechanistic insights to clinical translation. [PDF]
Wang F, Zhao J, Zhang T, Shi J.
europepmc +1 more source
Association Between Amino Acid Polymorphisms in MICA and MICA-NKG2D Interaction Affinity: Implications and Significance for Tumor Immunity. [PDF]
Xiao C +9 more
europepmc +1 more source
NKG2D receptor ligands are cell surface biomarkers for injured murine and human nociceptive sensory neurons. [PDF]
Wang S +14 more
europepmc +1 more source
A fully human IgG1 antibody targeting MICA α1 domain inhibits interaction with NKG2D and activates immune effector functions against MICA-expressing cells. [PDF]
Campos I +21 more
europepmc +1 more source
Natural Killer (NK) Cells in Tumor Immunity: Limitations and Therapeutic Potential with a Focus on Nasopharyngeal Carcinoma and Comparison with T-Cell-Based Therapies. [PDF]
Makowska A, Kontny U.
europepmc +1 more source
Cytotoxic lymphocyte heterogeneity in glioblastoma: insights from single-cell and spatial multiomics toward precision immunotherapeutic reprogramming. [PDF]
Dong W +8 more
europepmc +1 more source
The dual roles of natural killer cells in liver immunity and tolerance: Implications for health and disease. [PDF]
Li Z, Gong Y, Ye L, Liu W.
europepmc +1 more source
NKG2A+ NK cell cytotoxicity of Epstein-Barr virus infected B cells is mediated through the NKG2D and NKp30 activating receptors. [PDF]
Pena JK +9 more
europepmc +1 more source
Dual Regulation of Post-Translational Modification of Proteins: Bottlenecks and Breakthroughs in NK Cell Therapy for Glioblastoma. [PDF]
Liu Y +5 more
europepmc +1 more source

